Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Ophthalmology|August 1, 2018
Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderTing Shen, Yuyi You, Sukanya Arunachalam, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudyNathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.The Medical Journal of Australia|July 31, 2015
A new era in the treatment of multiple sclerosisSimon A Broadley, Michael H Barnett, Mike Boggild, et al.Nature Communications|December 20, 2019
CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndromeCatharina C Gross, Céline Meyer, Urvashi Bhatia, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Risk of relapse phenotype recurrence in multiple sclerosisTomas Kalincik, Katherine Buzzard, Vilija Jokubaitis, et al.Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.Frontiers in Neurology|July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.Pageof 7